A detailed history of Cornercap Investment Counsel Inc transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Cornercap Investment Counsel Inc holds 33,124 shares of GILD stock, worth $2.92 Million. This represents 0.38% of its overall portfolio holdings.

Number of Shares
33,124
Previous 27,099 22.23%
Holding current value
$2.92 Million
Previous $1.99 Million 14.46%
% of portfolio
0.38%
Previous 0.31%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 08, 2024

BUY
$63.15 - $72.88 $380,478 - $439,102
6,025 Added 22.23%
33,124 $2.27 Million
Q1 2024

May 10, 2024

SELL
$71.58 - $87.29 $16,606 - $20,251
-232 Reduced 0.85%
27,099 $1.99 Million
Q4 2023

Jan 30, 2024

BUY
$73.27 - $83.09 $39,639 - $44,951
541 Added 2.02%
27,331 $2.21 Million
Q3 2023

Nov 13, 2023

BUY
$73.94 - $80.67 $31,572 - $34,446
427 Added 1.62%
26,790 $2.01 Million
Q2 2023

Aug 11, 2023

SELL
$76.01 - $86.7 $124,276 - $141,754
-1,635 Reduced 5.84%
26,363 $2.03 Million
Q1 2023

May 11, 2023

BUY
$77.31 - $88.08 $77,541 - $88,344
1,003 Added 3.72%
27,998 $2.32 Million
Q4 2022

Feb 13, 2023

BUY
$62.32 - $89.47 $68,552 - $98,417
1,100 Added 4.25%
26,995 $2.32 Million
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $75,437 - $86,168
-1,267 Reduced 4.66%
25,895 $1.6 Million
Q2 2022

Aug 15, 2022

SELL
$57.72 - $65.01 $5,252 - $5,915
-91 Reduced 0.33%
27,162 $1.68 Million
Q1 2022

May 10, 2022

SELL
$57.92 - $72.58 $40,022 - $50,152
-691 Reduced 2.47%
27,253 $1.62 Million
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $215,661 - $244,779
-3,324 Reduced 10.63%
27,944 $2.03 Million
Q3 2021

Nov 15, 2021

SELL
$67.69 - $73.03 $11,101 - $11,976
-164 Reduced 0.52%
31,268 $2.18 Million
Q2 2021

Aug 16, 2021

SELL
$63.47 - $69.35 $158,738 - $173,444
-2,501 Reduced 7.37%
31,432 $2.16 Million
Q1 2021

May 13, 2021

BUY
$60.0 - $68.46 $2.04 Million - $2.32 Million
33,933 New
33,933 $2.19 Million
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $2.12 Million - $2.42 Million
-37,480 Closed
0 $0
Q3 2020

Nov 13, 2020

BUY
$62.1 - $78.08 $344,282 - $432,875
5,544 Added 17.36%
37,480 $2.37 Million
Q2 2020

Aug 13, 2020

BUY
$72.34 - $84.0 $2.31 Million - $2.68 Million
31,936 New
31,936 $2.46 Million
Q1 2018

May 15, 2018

SELL
$72.84 - $88.8 $210,580 - $256,720
-2,891 Closed
0 $0
Q4 2017

Feb 14, 2018

SELL
$71.15 - $83.52 $3.98 Million - $4.67 Million
-55,959 Reduced 95.09%
2,891 $208,000
Q3 2017

Nov 14, 2017

BUY
$72.11 - $85.47 $4.24 Million - $5.03 Million
58,850
58,850 $4.77 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $110B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Cornercap Investment Counsel Inc Portfolio

Follow Cornercap Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornercap Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cornercap Investment Counsel Inc with notifications on news.